Viridian Therapeutics, Inc.\DE (VRDN) Treasury Shares (2016 - 2025)
Historic Treasury Shares for Viridian Therapeutics, Inc.\DE (VRDN) over the last 7 years, with Q3 2025 value amounting to $1.1 million.
- Viridian Therapeutics, Inc.\DE's Treasury Shares rose 11192.5% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 11192.5%. This contributed to the annual value of $314075.0 for FY2024, which is 6098.19% down from last year.
- Per Viridian Therapeutics, Inc.\DE's latest filing, its Treasury Shares stood at $1.1 million for Q3 2025, which was up 11192.5% from $1.1 million recorded in Q2 2025.
- In the past 5 years, Viridian Therapeutics, Inc.\DE's Treasury Shares ranged from a high of $1.1 million in Q1 2025 and a low of $314075.0 during Q4 2024
- For the 3-year period, Viridian Therapeutics, Inc.\DE's Treasury Shares averaged around $663087.8, with its median value being $589696.0 (2024).
- Per our database at Business Quant, Viridian Therapeutics, Inc.\DE's Treasury Shares crashed by 6098.19% in 2024 and then soared by 11192.5% in 2025.
- Quarter analysis of 3 years shows Viridian Therapeutics, Inc.\DE's Treasury Shares stood at $804947.0 in 2023, then plummeted by 60.98% to $314075.0 in 2024, then skyrocketed by 247.19% to $1.1 million in 2025.
- Its last three reported values are $1.1 million in Q3 2025, $1.1 million for Q2 2025, and $1.1 million during Q1 2025.